wiki pageCreated: 2026-04-02T07:19:11By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-ncstn-protein
📖 Wiki Page
protein863 wordssynced 2026-04-02
Nicastrin (NCSTN Protein)
Introduction
Nicastrin (encoded by the [NCSTN gene](/genes/ncstn)) is an essential subunit of the [γ-secretase](/entities/gamma-secretase) complex that cleaves [amyloid precursor protein (APP)](/genes/app) and [Notch](/genes/notch1) receptors. As a gatekeeper for γ-secretase substrate access, nicastrin is central to [amyloid-β](/proteins/amyloid-beta-protein) production in [Alzheimer's disease](/diseases/alzheimers-disease).
Overview
Nicastrin is a type I transmembrane glycoprotein of ~130 kDa that serves as the substrate receptor of the γ-secretase complex<sup>[1]</sup>. The γ-secretase complex — composed of [presenilin-1](/genes/psen1) or [presenilin-2](/genes/psen2) (catalytic subunit), nicastrin, APH-1, and PEN-2 — is an intramembrane aspartyl protease essential for processing over 90 type I transmembrane substrates<sup>[2]</sup>. Nicastrin recognizes the N-terminus of substrate ectodomains after ectodomain shedding, gating substrate access to the presenilin active site. [@strooper2003]
Nicastrin (encoded by the [NCSTN gene](/genes/ncstn)) is an essential subunit of the [γ-secretase](/entities/gamma-secretase) complex that cleaves [amyloid precursor protein (APP)](/genes/app) and [Notch](/genes/notch1) receptors. As a gatekeeper for γ-secretase substrate access, nicastrin is central to [amyloid-β](/proteins/amyloid-beta-protein) production in [Alzheimer's disease](/diseases/alzheimers-disease).
Overview
Nicastrin is a type I transmembrane glycoprotein of ~130 kDa that serves as the substrate receptor of the γ-secretase complex<sup>[1]</sup>. The γ-secretase complex — composed of [presenilin-1](/genes/psen1) or [presenilin-2](/genes/psen2) (catalytic subunit), nicastrin, APH-1, and PEN-2 — is an intramembrane aspartyl protease essential for processing over 90 type I transmembrane substrates<sup>[2]</sup>. Nicastrin recognizes the N-terminus of substrate ectodomains after ectodomain shedding, gating substrate access to the presenilin active site. [@strooper2003]
Nicastrin has a large ectodomain and a single transmembrane pass<sup>[3]</sup>:
Large extracellular ectodomain (~670 aa): Aminopeptidase-like fold (catalytically inactive); contains the substrate-binding site
DAP domain: Peptidase-like domain that recognizes free N-termini of γ-secretase substrates
Lid domain: Covers the active site region; opens to admit substrates
Single transmembrane helix: Anchors nicastrin in the membrane; interacts with APH-1
Short cytoplasmic tail (~20 aa): Contains ER retention/retrieval signals
N-glycosylation: 16 potential N-glycosylation sites; heavy glycosylation critical for maturation and surface expression
γ-Secretase Complex Assembly
The four subunits assemble in a defined order in the ER<sup>[2]</sup>:
APH-1 + Nicastrin: Form the initial scaffold
+ Presenilin ([PSEN1](/entities/psen1)/2): Associates with the APH-1-Nicastrin dimer
+ PEN-2: Triggers presenilin endoproteolysis and complex activation
Mature complex: Traffics from ER → Golgi → plasma membrane/endosomes
Function
Substrate Gating
Nicastrin's ectodomain functions as the substrate receptor for γ-secretase<sup>[1]</sup>:
N-terminus recognition: Nicastrin's Glu333 (DAP domain) recognizes the free N-terminal stub of substrates after ectodomain shedding (by α- or β-secretase)
Size filter: Ectodomain acts as a molecular ruler — only substrates with short (<50 aa) residual ectodomains can access the presenilin active site
No enzymatic activity: Despite structural similarity to aminopeptidases, nicastrin has no catalytic activity
Demonstrates that partial γ-secretase loss affects Notch signaling before APP processing
Therapeutic Considerations
γ-Secretase inhibitors (GSIs): Non-selective GSIs failed in AD trials due to Notch toxicity (diarrhea, skin cancer risk)
γ-Secretase modulators (GSMs): Shift cleavage to produce shorter, less pathogenic Aβ38 without affecting Notch — nicastrin structure informs GSM design
Substrate-selective inhibitors: Targeting nicastrin's substrate recognition to selectively block APP processing while sparing Notch
[Shah S et al., Nicastrin functions as a gamma-secretase-substrate receptor (2005) (2005)](https://doi.org/10.1016/j.cell.2005.05.036)
[Unknown, De Strooper B, Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-secretase complex (2003) (2003)](https://doi.org/10.1016/S0896-6273(03)
[Xie T et al., Crystal structure of the gamma-secretase component nicastrin (2014) (2014)](https://doi.org/10.1073/pnas.1414837111)
[Unknown, Selkoe DJ & Hardy J, The amyloid hypothesis of Alzheimer's disease at 25 years (2016) (2016)](https://doi.org/10.15252/embj.201695957)
[Wang B et al., Gamma-secretase gene mutations in familial acne inversa (2010) (2010)](https://doi.org/10.1126/science.1196154)